Clinical trial
A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
NCT00207701 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00207701 |
|---|---|
| Title | A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis. |
| Official title | A Randomized, Double-blind Trial of the Efficacy of REMICADE (Infliximab) Compared With Placebo in Subjects With Ankylosing Spondylitis Receiving Standard Anti-inflammatory Drug Therapy |
| Lead sponsor | Centocor, Inc., Industry |
| Collaborators | Centocor BV Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | infliximab |
| Enrollment | 279 |
| Start date | Sep 1, 2002 |
| Completion | Feb 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: